What are the recommendations for using aspirin for a patient with definite or likely NSTE-ACS?
The recommendation is to use aspirin as an initial oral and intravenous antiplatelet therapy in patients with definite or likely NSTE-ACS treated with an initial invasive or ischemia-guided strategy.